A single-center experience with undifferentiated embryonal sarcoma of the liver

Melissa D. Mathias, Srikanth R. Ambati, Alexander J. Chou, Emily K. Slotkin, Leonard H. Wexler, Paul A. Meyers, Heather Magnan

Research output: Contribution to journalArticle

3 Scopus citations

Abstract

Undifferentiated embryonal sarcoma of the liver (UESL) is a rare aggressive mesenchymal pediatric tumor. Previously, reported outcomes have been very poor. Here, we report a single-center experience of five patients with UESL treated with upfront gross total resection and adjuvant chemotherapy. We have a median follow-up of 8 years with a range from 5 to 19 years with 100% event-free survival.

Original languageEnglish (US)
Pages (from-to)2246-2248
Number of pages3
JournalPediatric Blood and Cancer
Volume63
Issue number12
DOIs
StatePublished - Dec 1 2016

Keywords

  • case series
  • sarcoma
  • undifferentiated embryonal sarcoma of the liver

ASJC Scopus subject areas

  • Pediatrics, Perinatology, and Child Health
  • Hematology
  • Oncology

Fingerprint Dive into the research topics of 'A single-center experience with undifferentiated embryonal sarcoma of the liver'. Together they form a unique fingerprint.

  • Cite this

    Mathias, M. D., Ambati, S. R., Chou, A. J., Slotkin, E. K., Wexler, L. H., Meyers, P. A., & Magnan, H. (2016). A single-center experience with undifferentiated embryonal sarcoma of the liver. Pediatric Blood and Cancer, 63(12), 2246-2248. https://doi.org/10.1002/pbc.26154